Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Primær forebyggelse af kardiovaskulære hændelser med acetylsalicylsyre hos patienter med type 2-diabetes mellitus

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{577625d0b72041d5b061f2121f952f50,
title = "Prim{\ae}r forebyggelse af kardiovaskul{\ae}re h{\ae}ndelser med acetylsalicylsyre hos patienter med type 2-diabetes mellitus",
abstract = "This review assesses the latest evidence and guidelines related to the use of aspirin for primary prevention among patients with Type 2 diabetes (T2D) without overt cardiovascular disease. The global burden of T2D is steadily increasing and most deaths among patients with T2D are attributed to cardiovascular events. Furthermore, several haemostatic abnormalities have been shown in this group of patients, including increased platelet turnover and aggregation.",
author = "Victoria Rosberg and Grove, {Erik Lerkevang} and B{\o}tker, {Hans Erik} and Kristensen, {Steen Dalby} and Manan Pareek",
year = "2019",
language = "Dansk",
volume = "181",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "41",

}

RIS

TY - JOUR

T1 - Primær forebyggelse af kardiovaskulære hændelser med acetylsalicylsyre hos patienter med type 2-diabetes mellitus

AU - Rosberg, Victoria

AU - Grove, Erik Lerkevang

AU - Bøtker, Hans Erik

AU - Kristensen, Steen Dalby

AU - Pareek, Manan

PY - 2019

Y1 - 2019

N2 - This review assesses the latest evidence and guidelines related to the use of aspirin for primary prevention among patients with Type 2 diabetes (T2D) without overt cardiovascular disease. The global burden of T2D is steadily increasing and most deaths among patients with T2D are attributed to cardiovascular events. Furthermore, several haemostatic abnormalities have been shown in this group of patients, including increased platelet turnover and aggregation.

AB - This review assesses the latest evidence and guidelines related to the use of aspirin for primary prevention among patients with Type 2 diabetes (T2D) without overt cardiovascular disease. The global burden of T2D is steadily increasing and most deaths among patients with T2D are attributed to cardiovascular events. Furthermore, several haemostatic abnormalities have been shown in this group of patients, including increased platelet turnover and aggregation.

M3 - Tidsskriftartikel

C2 - 31610831

VL - 181

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 41

M1 - V03190205

ER -

ID: 58155022